Emmanuel Broni

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 27

Top Topics

Molecular Docking

Artificial Intelligence

Toxoplasma Gondii

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

Computation (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Carolyn N Ashley, Emmanuel Broni, Whelton A Miller
ADAR Family Proteins: A Structural Review. Current issues in molecular biology 46 (5) (2024)
Carolyn N Ashley, Emmanuel Broni, Whelton A Miller
ADAR Family Proteins: A Structural Review. Current issues in molecular biology 46 (5) (2024)
Moses N Arthur, Kristeen Bebla, Emmanuel Broni, Carolyn Ashley, Miriam Velazquez, Xianin Hua, Ravi Radhakrishnan, Samuel Kojo Kwofie, Whelton A Miller
Design of Inhibitors That Target the Menin-Mixed-Lineage Leukemia Interaction. Computation (Basel, Switzerland) 12 (1) (2023)
Nneka Ugwu-Korie, Osbourne Quaye, Edward Wright, Sylvester Languon, Odame Agyapong, Emmanuel Broni, Yash Gupta, Prakasha Kempaiah, Samuel Kojo Kwofie
Structure-Based Identification of Natural-Product-Derived Compounds with Potential to Inhibit HIV-1 Entry. Molecules (Basel, Switzerland) 28 (2) (2023)
Nneka Ugwu-Korie, Osbourne Quaye, Edward Wright, Sylvester Languon, Odame Agyapong, Emmanuel Broni, Yash Gupta, Prakasha Kempaiah, Samuel Kojo Kwofie
Structure-Based Identification of Natural-Product-Derived Compounds with Potential to Inhibit HIV-1 Entry. Molecules (Basel, Switzerland) 28 (2) (2023)
Emmanuel Broni, Whelton A Miller
Computational Analysis Predicts Correlations among Amino Acids in SARS-CoV-2 Proteomes. Biomedicines 11 (2) (2023)
Nneka Ugwu-Korie, Osbourne Quaye, Edward Wright, Sylvester Languon, Odame Agyapong, Emmanuel Broni, Yash Gupta, Prakasha Kempaiah, Samuel Kojo Kwofie
Structure-Based Identification of Natural-Product-Derived Compounds with Potential to Inhibit HIV-1 Entry. Molecules (Basel, Switzerland) 28 (2) (2023)
Emmanuel Broni, Carolyn Ashley, Miriam Velazquez, Sufia Khan, Andrew Striegel, Patrick O Sakyi, Saqib Peracha, Kristeen Bebla, Monsheel Sodhi, Samuel Kojo Kwofie, Adesanya Ademokunwa, Whelton A Miller
In Silico Discovery of Potential Inhibitors Targeting the RNA Binding Loop of ADAR2 and 5-HT2CR from Traditional Chinese Natural Compounds. International journal of molecular sciences 24 (16) (2023)
Samuel Kojo Kwofie, Joseph Adams, Emmanuel Broni, Kweku S Enninful, Mahmoud E S Soliman, Mahmoud E S Soliman, Michael David Wilson
Artificial Intelligence, Machine Learning, and Big Data for Ebola Virus Drug Discovery. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Nneka Ugwu-Korie, Osbourne Quaye, Edward Wright, Sylvester Languon, Odame Agyapong, Emmanuel Broni, Yash Gupta, Prakasha Kempaiah, Samuel Kojo Kwofie
Structure-Based Identification of Natural-Product-Derived Compounds with Potential to Inhibit HIV-1 Entry. Molecules (Basel, Switzerland) 28 (2) (2023)
Emmanuel Broni, Whelton A Miller
Computational Analysis Predicts Correlations among Amino Acids in SARS-CoV-2 Proteomes. Biomedicines 11 (2) (2023)
Patrick O Sakyi, Samuel Kojo Kwofie, Julius K Tuekpe, Theresa M Gwira, Emmanuel Broni, Whelton A Miller, Michael David Wilson, Richard Kwamla Amewu
Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Emmanuel Broni, Andrew Striegel, Carolyn Ashley, Patrick O Sakyi, Saqib Peracha, Miriam Velazquez, Kristeen Bebla, Monsheel Sodhi, Samuel Kojo Kwofie, Adesanya Ademokunwa, Sufia Khan, Whelton A Miller
Molecular Docking and Dynamics Simulation Studies Predict Potential Anti-ADAR2 Inhibitors: Implications for the Treatment of Cancer, Neurological, Immunological and Infectious Diseases. International journal of molecular sciences 24 (7) (2023)
Moses N Arthur, Kristeen Bebla, Emmanuel Broni, Carolyn Ashley, Miriam Velazquez, Xianin Hua, Ravi Radhakrishnan, Samuel Kojo Kwofie, Whelton A Miller
Design of Inhibitors That Target the Menin-Mixed-Lineage Leukemia Interaction. Computation (Basel, Switzerland) 12 (1) (2023)
Emmanuel Broni, Carolyn Ashley, Joseph Adams, Hammond Manu, Ebenezer Aikins, Mary Okom, Whelton A Miller, Michael David Wilson, Samuel Kojo Kwofie
Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors. International journal of molecular sciences 24 (7) (2023)
Nneka Ugwu-Korie, Osbourne Quaye, Edward Wright, Sylvester Languon, Odame Agyapong, Emmanuel Broni, Yash Gupta, Prakasha Kempaiah, Samuel Kojo Kwofie
Structure-Based Identification of Natural-Product-Derived Compounds with Potential to Inhibit HIV-1 Entry. Molecules (Basel, Switzerland) 28 (2) (2023)
Samuel Kojo Kwofie, Joseph Adams, Emmanuel Broni, Kweku S Enninful, Mahmoud E S Soliman, Mahmoud E S Soliman, Michael David Wilson
Artificial Intelligence, Machine Learning, and Big Data for Ebola Virus Drug Discovery. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Samuel Kojo Kwofie, Joseph Adams, Emmanuel Broni, Kweku S Enninful, Mahmoud E S Soliman, Mahmoud E S Soliman, Michael David Wilson
Artificial Intelligence, Machine Learning, and Big Data for Ebola Virus Drug Discovery. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Patrick O Sakyi, Samuel Kojo Kwofie, Julius K Tuekpe, Theresa M Gwira, Emmanuel Broni, Whelton A Miller, Michael David Wilson, Richard Kwamla Amewu
Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Patrick O Sakyi, Samuel Kojo Kwofie, Julius K Tuekpe, Theresa M Gwira, Emmanuel Broni, Whelton A Miller, Michael David Wilson, Richard Kwamla Amewu
Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Emmanuel Broni, Whelton A Miller
Computational Analysis Predicts Correlations among Amino Acids in SARS-CoV-2 Proteomes. Biomedicines 11 (2) (2023)
Moses N Arthur, Kristeen Bebla, Emmanuel Broni, Carolyn Ashley, Miriam Velazquez, Xianin Hua, Ravi Radhakrishnan, Samuel Kojo Kwofie, Whelton A Miller
Design of Inhibitors That Target the Menin-Mixed-Lineage Leukemia Interaction. Computation (Basel, Switzerland) 12 (1) (2023)
Emmanuel Broni, Samuel Kojo Kwofie, Seth Osei Asiedu, Whelton A Miller, Michael David Wilson
A Molecular Modeling Approach to Identify Potential Antileishmanial Compounds Against the Cell Division Cycle (cdc)-2-Related Kinase 12 (CRK12) Receptor of Leishmania donovani. Biomolecules 11 (3) (2021)
Samuel K Kwofie, Emmanuel Broni, Seth O Asiedu, Gabriel B Kwarko, Bismark Dankwa, Kweku S Enninful, Elvis K Tiburu, Michael David Wilson
Cheminformatics-Based Identification of Potential Novel Anti-SARS-CoV-2 Natural Compounds of African Origin. Molecules (Basel, Switzerland) 26 (2) (2021)
Louis K S Darko, Emmanuel Broni, Dominic Selorm Yao Amuzu, Michael David Wilson, Christian S Parry, Samuel Kojo Kwofie
Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds. Biomedicines 9 (12) (2021)
Seth Osei Asiedu, Samuel Kojo Kwofie, Emmanuel Broni, Michael David Wilson
Computational Identification of Potential Anti-Inflammatory Natural Compounds Targeting the p38 Mitogen-Activated Protein Kinase (MAPK): Implications for COVID-19-Induced Cytokine Storm. Biomolecules 11 (5) (2021)
Samuel Kojo Kwofie, Emmanuel Broni, Faruk U Yunus, John Nsoh, Dela Adoboe, Whelton A Miller, Michael David Wilson
Molecular Docking Simulation Studies Identifies Potential Natural Product Derived-Antiwolbachial Compounds as Filaricides against Onchocerciasis. Biomedicines 9 (11) (2021)